Alomone Labs

Hangzhou AllTest Biotech Co., Ltd is located in 550#，Yinhai Street, Baiyang District, Hangzhou Economic-Technological Development Area, the company registered capital of 15 million RMB. The company’s total construction area is about 3200 M2. The company holds strong ability of scientific research and innovative technology. AllTest Biotech leads the development frontier of biological technologies such as monoclonal antibody-colloidal gold and latex technique, gene engineering, compound antigen and immunoassay.

AllTest Biotech is thriving on design, development, manufacturing and sales of the lateral flow rapid IVD products and food safety test product. The product is broadly recognized in the international market for its rapid, convenience and accurateness. AllTest Biotech will strive to become the leader and pioneer in the diagnostic industry field of China and the world.

Eurofins Advinus is your trusted partner for specialized discovery, preclinical and early clinical services. Our facility has 30 years of GLP experience in conducting regulatory studies in compliance with global regulations for supporting clinical trials and registration of substances and products globally.

We have over a decade of drug discovery experience for novel, first-in-class targets as well as fast follow on targets and have produced multiple assets that are in preclinical and clinical development. Our discovery services include comprehensive offerings from Medicinal Chemistry, to in vitro Biology, ADMET and Pharmacology.

We offer end-to-end services for a complete IND/IMPD package that includes Safety Assessment/Toxicology and Drug Metabolism and Pharmacokinetic (DMPK) studies along with Chemistry, Manufacturing and Controls (CMC) services.

DMPK services include full spectrum of in vitro screening services, assay development and validation with customized assays and PK studies. We also provide bioanalytical assay development and validation services in accordance with USFDA and EMA guidelines for both Novel Chemical Entities (NCEs), as well as Novel Biological Entities (NBEs) and Biosimilars.

We have successfully submitted enabled 80+ IND packages for submission to regulatory agencies across the world – including USFDA, MHA and EMA. We offer full range of toxicology services to support NDA filing. We have completed 65+ carcinogenicity studies.

Abbkine Scientific Co., Ltd. was founded by a number of scientists and marketing experts in the field of life science in California in 2012. With growing demands from Asia Pacific, it move its headquarters to China. Abbkine started featured and exclusive products from protein detection tools, and devoted to developing and providing the most innovative solutions for global customers covering all kinds of antibodies, biochemicals, proteins and assay kits. We're pround to provide below featured portfolio and will continue focusing on providing innovative, high quality and cost-effective life science research and diagnosis products.

ImmunoDiagnostics Limited (IMD) is a spin-off biotech company from The University of Hong Kong. The company is dedicated to biomarker discovery, assay development and in vitro diagnostics (IVD) of major chronic diseases, particularly on cardio-metabolic diseases and autoimmune diseases.
The company has established an integrated “biomarker/antigen-antibody-immunoassay” pipeline for the development of innovative diagnostic products. Firstly, new biomarkers are expressed in the form of recombinant proteins with different protein expression systems and are subsequently purified to a final purity of above 95% by procedures such as affinity purification, ion-exchange chromatography, size exclusion chromatography and gel infiltration. Secondly, by using high-quality recombinant proteins as antigens, antibodies are generated in the serum of host animals such as rabbits or mice after immunization and are further purified from the serum by performing both IgG- and antigen-based affinity purification; Lastly, highly specific antibodies are used for the development of a series of innovative semi- or fully automatic immunoassays with supreme sensitivity, specificity and efficiency, including immunoblotting assays, enzyme-linked immunosorbent assays (ELISAs), as well as immunoturbidimetry assays (ITAs), chemiluminescence assays (CLIAs), which can be directly applied in clinical diagnosis.

KYinno is dedicated to oncology drug discovery service and customized product development, with a focus on immuno-oncology and next-generation kinase inhibitor discovery.

Our service platforms include:
- Engineered custom cell line development
- Cell-based assay validation and compound screening
- Phage display library and hybridoma technology for antibody drug discovery
- Cancer cell panel compound profiling and biomarker discovery

Our products include:
- Engineered reporter cell lines
- Antibody and proteins with fully validated functions in reporter cell lines

Our team members have years of experience in the pharmaceutical and biotechnology industry in both China and U.S.